GLP-1 agonists may lead to increased nausea and vomiting in the early postoperative period after total hip arthroplasty, ...

Brown-Forman stays steady through cost cutting but faces tough 2025. Read why BF.A stock might struggle despite its flagship ...

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

The rise of GLP-1 drugs like Ozempic are changing consumer food waste patterns both at home and in restaurant settings.

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

While most guidelines require 6 months of behavioral interventions before prescribing weight-loss drugs, new research shows ...

The line-up consists of supplements to meet the health needs to patients taking GLP-1 medications for weight loss.

T2D has been associated with an increased risk of CV mortality and GLP-1RAs are being increasingly used as a T2D and obesity ...

Researchers say payers should take the added costs of drugs prescribed to deal with GLP-1 side effects into account when ...

Questions about insurance coverage for weight-loss drugs are getting more intense as cheaper alternatives go off the market.